The Role of CJC-1295 and Ipamorelin in Growth Hormone Therapy Research

Abstract Peptide-based therapeutics are gaining significant traction in endocrine and regenerative medicine. Among them, CJC-1295 and Ipamorelin stand out as potent Growth Hormone Secretagogues (GHS) that act through Growth Hormone-Releasing Hormone (GHRH) and ghrelin receptor pathways, respectively. Their synergistic potential to increase pulsatile GH release without elevating prolactin or cortisol has made them promising candidates […]
Thymosin Beta-4 (TB-500): Accelerating Recovery in Musculoskeletal Injuries

Abstract Musculoskeletal injuries—particularly those involving tendons, ligaments, and skeletal muscle—remain a significant burden in both sports medicine and orthopedic recovery. Among emerging therapeutic peptides, Thymosin Beta-4 (TB-500) has demonstrated promise in accelerating tissue repair, modulating inflammation, and promoting angiogenesis. TB-500 is a synthetic fragment of the naturally occurring 43-amino acid peptide Thymosin Beta-4, which plays […]
N-Acetyl Epitalon Amidate (Epithalon) : Telomerase Activation and Circadian Rhythm Modulation in the Context of Age-Related Decline

Abstract The search for pharmacological interventions capable of delaying age-associated molecular decay has intensified in recent decades. Among emerging candidates, N-Acetyl Epitalon Amidate (commonly referred to as Epithalon) has garnered significant attention due to its potential role in telomerase activation, circadian rhythm modulation, and systemic rejuvenation. Originally developed at the St. Petersburg Institute of Bioregulation […]